Earnings

Helus Pharma Q1 EPS $(0.91) Beats $(1.07) Estimate

Aug 14, 2026 · 07:53 AM ET· updated 1h ago

Helus Pharma (NASDAQ:HELP) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(1.07) by 14.95 percent. This is a 17.27 percent increase over losses of $(1.10) per share from the

Why It Matters

Helus Pharma lost less money than people expected, which is good news when a company is still unprofitable. Watch whether the company keeps improving and gets closer to making actual profit, because that shows the business is getting healthier.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HELP11.55

+0.10 (+0.89%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.